Methenamine Hippurate Tablets, USP
- Manufacturer
- Zydus Lifesciences Limited | Zydus Pharmaceuticals Limited
- Effective date
- 2025-03-12
- Label type
- HUMAN PRESCRIPTION DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-05-31 21:27:27
Label at a glance#
Label contents#
Full prescribing information#
DailyMed RxNorm Mappings#
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 260b0da6-d3d7-262f-a60f-d4b36d5f1b4d | Product name | 6 | 20251210 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70771-1919-1 | Methenamine hippurate | 100 in 1 BOTTLE | TABLET | 100 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 70771-1919 | METHENAMINE HIPPURATE TABLET [ZYDUS LIFESCIENCES LIMITED] | 1 | Current NDC, 1 package rows | 20250315_7e0d13d1-e564-4f3e-9054-65161eddfc57.zip |
Products#
Every source-derived product name is available through these pages.
- Methenamine hippurate
- METHENAMINE
- CROSPOVIDONE, UNSPECIFIED
- MAGNESIUM STEARATE
- POVIDONE, UNSPECIFIED
- SACCHARIN SODIUM
- SILICON DIOXIDE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 70771-1919 | 70771-1919-1 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| METHENAMINE HIPPURATE | M329791L57 | ACTIB |
| CROSPOVIDONE, UNSPECIFIED | 2S7830E561 | IACT |
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
| POVIDONE, UNSPECIFIED | FZ989GH94E | IACT |
| SACCHARIN SODIUM | SB8ZUX40TY | IACT |
| SILICON DIOXIDE | ETJ7Z6XBU4 | IACT |
Source Document#
Orange Book application contexts#
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A219661-001 | METHENAMINE HIPPURATE | METHENAMINE HIPPURATE | 1GM | TABLET / ORAL | AB | 2025-03-10 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A219661-001 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A219661-001 | METHENAMINE HIPPURATE | 1GM | TABLET / ORAL | AB | 2025-03-10 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A219661-001 | METHENAMINE HIPPURATE | 1GM | TABLET / ORAL | AB | 2025-03-10 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A219661-001 | METHENAMINE HIPPURATE | 1GM | TABLET / ORAL | AB | 2025-03-10 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A219661-001 | METHENAMINE HIPPURATE | 1GM | TABLET / ORAL | AB | 2025-03-10 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A219661-001 | METHENAMINE HIPPURATE | 1GM | TABLET / ORAL | AB | 2025-03-10 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A219661-001 | METHENAMINE HIPPURATE | 1GM | TABLET / ORAL | AB | 2025-03-10 | fd3edfee7708… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A219661-001 | METHENAMINE HIPPURATE | 1GM | TABLET / ORAL | AB | 2025-03-10 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A219661-001 | AB | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A219661-001 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A219661-001 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A219661-001 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A219661-001 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A219661-001 | AB | 1 | fd3edfee7708… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A219661-001 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Methenamine hippurate | METHENAMINE HIPPURATE | Zydus Lifesciences Limited | 7e0d13d1-e564-4f3e-9054-65161eddfc57 | 2025-03-12 | 70771-1919-1 70771-1919 70771191901 c3524692-fabc-438a-9d6e-2cca27172693 7e0d13d1-e564-4f3e-9054-65161eddfc57 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
